RESUMO
Uterine myomas are found in 0.3-2.6% of pregnant women. In one case out of ten they cause complications. Treatment is primarily conservative but in cases of failure, surgery cannot be avoided. We present a case of a pregnant woman with myomas. Because of failure of conservative management and severe abdominal pain, we performed a myomectomy at 18 weeks' gestation with preservation of the pregnancy. We describe a modified surgical technique whereby interrupted sutures are first placed around the myoma for haemostasis. We achieved good pregnancy outcome by caesarean section carried out near term. Incidence, presentation, and challenges associated with the management of myomas during pregnancy are briefly discussed.
Assuntos
Procedimentos Cirúrgicos em Ginecologia/métodos , Leiomioma/cirurgia , Complicações Neoplásicas na Gravidez/cirurgia , Neoplasias Uterinas/cirurgia , Adulto , Perda Sanguínea Cirúrgica/prevenção & controle , Cesárea , Feminino , Humanos , Leiomioma/diagnóstico por imagem , Ligadura/métodos , Gravidez , Complicações Neoplásicas na Gravidez/diagnóstico por imagem , Resultado da Gravidez , Técnicas de Sutura , Aderências Teciduais/prevenção & controle , Resultado do Tratamento , Ultrassonografia , Neoplasias Uterinas/diagnóstico por imagemRESUMO
Recurrent pregnancy loss is a disease of grave psychological and economic concern. The etiology in the vast majority of the cases is unknown or at best poorly understood. Although Klebsiella pneumonia infections have been reported in humans and animals during pregnancy, there is hardly any information to indicate whether or not these infections may be responsible for early pregnancy loss. We present a review of literature and report for the first time in humans, Klebsiella pneumonia infection in placenta of a 38-year-old secondary recurrent aborter (parity 2 + 3).
Assuntos
Aborto Espontâneo/microbiologia , Doenças do Recém-Nascido/mortalidade , Infecções por Klebsiella/mortalidade , Klebsiella pneumoniae , Exposição Ocupacional , Complicações Infecciosas na Gravidez/microbiologia , Aborto Habitual/microbiologia , Adulto , Feminino , Humanos , Recém-Nascido , Doenças do Recém-Nascido/microbiologia , Infecções por Klebsiella/epidemiologia , Masculino , Placenta/microbiologia , Gravidez , Fatores de Risco , Sêmen/microbiologiaRESUMO
UNLABELLED: Rhabdomyosarcomas are the most common soft tissue sarcomas in childhood. The botryoid variant arises in infancy from the vagina or urinary bladder and extremely rarely from the uterine cervix. Treatment regimes range from local excision of the tumour to radical hysterectomy with adjuvant multidrug therapy and/or radiotherapy. In cases of minimal cervical invasion, the less invasive local excision in combination with adjuvant chemotherapy has resulted in excellent survival rates with complete functional preservation of the bladder, rectum, vagina, and ovaries. We present here a 30-year literature review and a case report of a cervical sarcoma botryoides in a 5-year-old girl. CONCLUSION: based on the literature review and our own observation, we recommend minor surgical approaches in combination with chemotherapy as the treatment of choice for early stage I cervical rhabdomyosarcoma.
Assuntos
Rabdomiossarcoma Embrionário/patologia , Rabdomiossarcoma Embrionário/terapia , Neoplasias do Colo do Útero/patologia , Neoplasias do Colo do Útero/terapia , Protocolos de Quimioterapia Combinada Antineoplásica , Quimioterapia Adjuvante , Pré-Escolar , Dactinomicina/uso terapêutico , Feminino , Humanos , Ifosfamida/uso terapêutico , Estadiamento de Neoplasias , Vincristina/uso terapêuticoRESUMO
Recurrent pregnancy loss has been associated with autoimmune responses to membrane phospholipids and alloimmune reactions against paternally derived molecules on the trophoblast. The problem is psychologically and economically stressful as it undermines the capacity of some couples to reproduce and participate effectively in the day-to-day economic activities. This article reviews the adoption of intravenous immunoglobulin as a form of therapy for the clinical management of recurrent pregnancy loss and of selected autoimmune disorders. Side effects, contraindications and safety of use are discussed.